Skip to main content

Want a detailed portfolio tracker?

Alector (ALEC) P/E (2019 - 2026)

Alector (ALEC) P/E from Apr 1, 2019 to Jul 21, 2026. The TTM Alector (ALEC) P/E is -1.32. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Alector (ALEC)

YearP/EChange
2026-1.32+15.46%
2025-1.14-26.09%
2024-1.54-67.20%
2023-4.71-15.07%
2022-5.54-88.57%
2021-48.50+671.01%
2020-6.29-44.18%
2019-11.27N/A

Comparison Alector (ALEC) P/E with competitors

Alector (ALEC) P/E is -1.32.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.13%
NBYStablecoin Development Corp0.00-100.33%
ENLVEnlivex Ltd0.07-105.68%
FGENFibroGen Inc0.24-118.21%
CHRSCoherus Biosciences Inc0.85-164.38%
FBIOFortress Biotech Inc0.95-172.00%
ORMPOramed Pharmaceuticals Inc1.50-214.04%
AGENAgenus Inc3.01-328.34%
INVAInnoviva Inc3.15-339.30%
VXRTVaxart Inc3.55-369.32%
CRMDCorMedix Inc3.63-375.29%
CVACCureVac N.V.4.45-437.30%
GLPGGalapagos NV4.86-468.65%
SRPTSarepta Therapeutics Inc4.88-470.41%
ABEOAbeona Therapeutics Inc5.39-508.75%
ABUSArbutus Biopharma Corp5.60-524.54%
ZVRAZevra Therapeutics Inc5.89-546.67%
SPROSpero Therapeutics Inc6.23-572.56%
CGENCompugen Ltd6.31-579.04%
RIGLRigel Pharmaceuticals6.87-621.39%
SLXNSilexion Therapeutics Corp7.30-653.56%
OMEROmeros Corporation9.26-802.47%
AUPHAurinia Pharmaceuticals Inc9.58-827.22%
PLXProtalix BioTherapeutics Inc10.89-926.31%
ACADAcadia Pharmaceuticals Inc11.73-989.85%
TBPHTheravance Biopharma Inc12.26-1030.34%
ADMAAdma Biologics Inc12.42-1042.17%
HRMYHarmony Biosciences Holdings Inc13.82-1148.55%
SABSSAB Biotherapeutics Inc14.14-1172.53%
NAGENiagen Bioscience Inc14.82-1224.26%
INCYIncyte Corp15.82-1300.47%
REGNRegeneron Pharmaceuticals Inc15.86-1303.06%
PBYIPuma Biotechnology Inc17.32-1413.76%
CPRXCatalyst Pharmaceuticals Inc17.44-1423.14%
EXELExelixis Inc17.54-1430.62%
TGTXTG Therapeutics Inc18.97-1538.97%
MDXGMimedx Group Inc20.55-1659.34%
XOMAXOMA Royalty Corp22.87-1835.57%
ARGXArgen X SE24.30-1943.56%
CTMXCytomX Therapeutics Inc24.82-1983.25%
XOMAOXOMA Royalty Corp25.34-2022.98%
HALOHalozyme Therapeutics Inc25.62-2044.15%
XOMAPXOMA Royalty Corp25.67-2047.67%
VRTXVertex Pharmaceuticals Inc27.99-2224.04%
RPRXRoyalty Pharma plc - Class A28.69-2276.61%
SLNOSoleno Therapeutics Inc29.02-2301.48%
ASNDAscendis Pharma A/S30.09-2382.68%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2976.50%
APLSApellis Pharmaceuticals Inc39.02-3060.65%
BMRNBiomarin Pharmaceutical Inc42.21-3302.74%
KRYSKrystal Biotech Inc45.34-3540.34%
ONCBeiGene Ltd69.54-5376.24%
PHARPharming Group N.V.75.03-5792.41%
TECHBio-Techne Corp101.96-7835.88%
VCELVericel Corp109.92-8440.06%
ALNYAlnylam Pharmaceuticals Inc117.96-9050.36%
GMABGenmab140.29-10744.28%
TLXTelix Pharmaceuticals Ltd162.15-12403.02%
CORTCorcept Therapeutics Inc212.86-16250.13%